Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ziteng Liang

Showing results (11-20 of 32) with videos related to

Pageof 4
Sort By:
Emerging Microbes & Infections|June 14, 2023
Sera from breakthrough infections with SARS-CoV-2 BA.5 or BF.7 showed lower neutralization activity against XBB.1.5 and CH.1.1Shuo Liu, Ziteng Liang, Jianhui Nie, et al.
Cell Discovery|August 17, 2022
A broader neutralizing antibody against all the current VOCs and VOIs targets unique epitope of SARS-CoV-2 RBDShuo Liu, Zijing Jia, Jianhui Nie, et al.
Cell Discovery|December 8, 2023
Author Correction: A broader neutralizing antibody against all the current VOCs and VOIs targets unique epitope of SARS-CoV-2 RBDShuo Liu, Zijing Jia, Jianhui Nie, et al.
Emerging Microbes & Infections|December 10, 2021
The significant immune escape of pseudotyped SARS-CoV-2 variant OmicronLi Zhang, Qianqian Li, Ziteng Liang, et al.
Journal of Medical Virology|January 23, 2024
Immune escape of BA.2.86 is comparable to XBB subvariants from the plasma of BA.5- and BA.5-XBB-convalescent subpopulationsXiaoyun Yang, Yuan Wang, Ziteng Liang, et al.
Medcomm|March 25, 2024
Development of a SARS-CoV-2 neutralization assay based on a pseudotyped virus using a HIV systemZiteng Liang, Jincheng Tong, Xi Wu, et al.
Journal of Hazardous Materials|January 20, 2026
Multi-omics reveals taxonomic and functional adaptations of soil microbiota to Bt toxin exposureLuyao Wang, Ziteng Liang, Jingang Liang, et al.
Emerging Microbes & Infections|November 24, 2021
Reduced sensitivity of the SARS-CoV-2 Lambda variant to monoclonal antibodies and neutralizing antibodies induced by infection and vaccinationMeiyu Wang, Li Zhang, Qianqian Li, et al.
Medcomm|June 17, 2024
Optimization and validation of a virus-like particle pseudotyped virus neutralization assay for SARS-CoV-2Shuo Liu, Li Zhang, Wangjun Fu, et al.
Emerging Microbes & Infections|September 20, 2023
Development of an automated, high-throughput SARS-CoV-2 neutralization assay based on a pseudotyped virus using a vesicular stomatitis virus (VSV) vectorZiteng Liang, Xi Wu, Jiajing Wu, et al.
Pageof 4

Showing results (11-20 of 32) with videos related to

Sort By:
Pageof 4
Emerging Microbes & Infections|June 14, 2023
Sera from breakthrough infections with SARS-CoV-2 BA.5 or BF.7 showed lower neutralization activity against XBB.1.5 and CH.1.1Shuo Liu, Ziteng Liang, Jianhui Nie, et al.
Cell Discovery|August 17, 2022
A broader neutralizing antibody against all the current VOCs and VOIs targets unique epitope of SARS-CoV-2 RBDShuo Liu, Zijing Jia, Jianhui Nie, et al.
Cell Discovery|December 8, 2023
Author Correction: A broader neutralizing antibody against all the current VOCs and VOIs targets unique epitope of SARS-CoV-2 RBDShuo Liu, Zijing Jia, Jianhui Nie, et al.
Emerging Microbes & Infections|December 10, 2021
The significant immune escape of pseudotyped SARS-CoV-2 variant OmicronLi Zhang, Qianqian Li, Ziteng Liang, et al.
Journal of Medical Virology|January 23, 2024
Immune escape of BA.2.86 is comparable to XBB subvariants from the plasma of BA.5- and BA.5-XBB-convalescent subpopulationsXiaoyun Yang, Yuan Wang, Ziteng Liang, et al.
Medcomm|March 25, 2024
Development of a SARS-CoV-2 neutralization assay based on a pseudotyped virus using a HIV systemZiteng Liang, Jincheng Tong, Xi Wu, et al.
Journal of Hazardous Materials|January 20, 2026
Multi-omics reveals taxonomic and functional adaptations of soil microbiota to Bt toxin exposureLuyao Wang, Ziteng Liang, Jingang Liang, et al.
Emerging Microbes & Infections|November 24, 2021
Reduced sensitivity of the SARS-CoV-2 Lambda variant to monoclonal antibodies and neutralizing antibodies induced by infection and vaccinationMeiyu Wang, Li Zhang, Qianqian Li, et al.
Medcomm|June 17, 2024
Optimization and validation of a virus-like particle pseudotyped virus neutralization assay for SARS-CoV-2Shuo Liu, Li Zhang, Wangjun Fu, et al.
Emerging Microbes & Infections|September 20, 2023
Development of an automated, high-throughput SARS-CoV-2 neutralization assay based on a pseudotyped virus using a vesicular stomatitis virus (VSV) vectorZiteng Liang, Xi Wu, Jiajing Wu, et al.
Pageof 4